Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-18 6:31 pm Purchase | 2025-12-18 | 13D | Vor Biopharma Inc. VOR | RA CAPITAL MANAGEMENT L.P. | 5,411,521 14.000% | 3,066,244 (+130.74%) | Filing History |
| 2025-12-18 6:07 pm Purchase | 2025-12-11 | 13G | Ovid Therapeutics Inc. OVID | RA CAPITAL MANAGEMENT L.P. | 13,259,735 9.900% | 13,259,735 (New Position) | Filing History |
| 2025-12-18 5:22 pm Purchase | 2025-12-11 | 13G | Rezolute, Inc. RZLT | RA CAPITAL MANAGEMENT L.P. | 15,302,186 9.900% | 15,302,186 (New Position) | Filing History |
| 2025-12-15 7:56 pm Sale | 2025-12-11 | 13D | Climb Bio, Inc. CLYM | RA CAPITAL MANAGEMENT L.P. | 18,003,257 33.000% | -13,456,010 (-42.77%) | Filing History |
| 2025-12-15 5:04 pm Unchanged | 2025-12-11 | 13D | Wave Life Sciences Ltd. WVE | RA CAPITAL MANAGEMENT L.P. | 25,453,010 13.400% | 0 (Unchanged) | Filing History |
| 2025-12-12 5:14 pm Unchanged | 2025-12-05 | 13D | Perceptive Capital Solutions Corp Class A Ordinary Shares PCSC | RA CAPITAL MANAGEMENT L.P. | 750,000 8.400% | 0 (Unchanged) | Filing History |
| 2025-12-10 4:44 pm Sale | 2025-12-08 | 13G | Fulcrum Therapeutics, Inc. FULC | RA CAPITAL MANAGEMENT L.P. | 6,053,960 11.200% | -4,175,139 (-40.82%) | Filing History |
| 2025-12-03 4:22 pm Purchase | 2025-11-07 | 13G | Benitec Biopharma Inc. BNTC | RA CAPITAL MANAGEMENT L.P. | 1,850,000 5.500% | 1,850,000 (New Position) | Filing History |
| 2025-11-17 4:44 pm Purchase | 2025-11-07 | 13D | Evommune, Inc. EVMN | RA CAPITAL MANAGEMENT L.P. | 3,458,770 11.000% | 3,458,770 (New Position) | Filing History |
| 2025-11-17 4:39 pm Unchanged | 2025-11-13 | 13D | Cidara Therapeutics, Inc. CDTX | RA CAPITAL MANAGEMENT L.P. | 3,372,923 10.700% | 0 (Unchanged) | Filing History |
| 2025-11-14 6:13 pm Purchase | 2025-11-12 | 13D | Vor Biopharma Inc. VOR | RA CAPITAL MANAGEMENT L.P. | 2,345,277 9.900% | 1,534,606 (+189.30%) | Filing History |
| 2025-11-14 4:20 pm Purchase | 2025-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY | RA CAPITAL MANAGEMENT L.P. | 1,960,230 9.900% | 1,960,230 (New Position) | Filing History |
| 2025-11-14 4:19 pm Sale | 2025-09-30 | 13G | Tourmaline Bio, Inc. TRML | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -2,538,925 (Position Closed) | Filing History |
| 2025-11-14 4:18 pm Purchase | 2025-09-30 | 13G | Taysha Gene Therapies, Inc. TSHA | RA CAPITAL MANAGEMENT L.P. | 27,662,481 9.900% | 2,316,493 (+9.14%) | Filing History |
| 2025-11-14 4:17 pm Sale | 2025-09-30 | 13G | RxSight, Inc. RXST | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -3,916,825 (Position Closed) | Filing History |
| 2025-11-14 4:16 pm Purchase | 2025-09-30 | 13G | Monopar Therapeutics Inc. MNPR | RA CAPITAL MANAGEMENT L.P. | 742,861 9.900% | 122,745 (+19.79%) | Filing History |
| 2025-11-14 4:15 pm Purchase | 2025-09-30 | 13G | Edgewise Therapeutics, Inc. EWTX | RA CAPITAL MANAGEMENT L.P. | 10,428,437 9.900% | 1,519,346 (+17.05%) | Filing History |
| 2025-11-14 4:14 pm Sale | 2025-09-30 | 13G | Dyne Therapeutics, Inc. DYN | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -9,714,392 (Position Closed) | Filing History |
| 2025-11-14 4:13 pm Purchase | 2025-09-30 | 13G | Dianthus Therapeutics, Inc. DNTH | RA CAPITAL MANAGEMENT L.P. | 3,866,733 9.500% | 1,000,000 (+34.88%) | Filing History |
| 2025-11-14 4:13 pm Purchase | 2025-09-30 | 13G | Avidity Biosciences, Inc. RNA | RA CAPITAL MANAGEMENT L.P. | 8,641,031 5.900% | 2,340,623 (+37.15%) | Filing History |